In Italy, the process of power decentralization to Regional Governments has particularly affected pharmaceutical care policies. Regions are experimenting with various strategies to govern drugs utilization and expenditure, and differentiating their approaches, leading to an ever-changing and...

<i> Politiche regionali e variabilità della spesa farmaceutica convenzionata </i> (di Simone Gerzeli, Claudio Jommi, Stefano Villa) - ABSTRACT: The research aims at evaluating the relationship between different regional policies and the cross-regional variability in the public per capitapharmaceutical...

We provide the first empirical results of the impact of GRP on prices in Italy and evidence that GRP cannot be held solely responsible for the often reported demand reallocation towards new and in-patent molecules. </AbstractSection> Copyright Springer-Verlag Berlin Heidelberg 2013

Pharmaceutical policy in Italy has been reshaped as a result of the 1993-4 crisis in which it was revealed that pharmaceutical companies, policy makers and top Department of Health officers had constructed an illegal system to set prices. Following this crisis, the rise of technical competency...

To investigate the organisation and decision-making processes of regional and local therapeutic committees in Italy, as a case-study of decentralised health care systems.